The health and safety of patients is at the center of everything Nucro-Technics does. The work performed at our facility supports both the development of new drug candidates for human and veterinary medicine, as well as the quality testing required before established treatments reach patients. These therapies address some of the most serious conditions [...]
August 15, 2023: Frontage Laboratories, Inc. and its wholly-owned subsidiary, Frontage Canada, Inc., completed the acquisition of Nucro-Technics Inc. and its affiliate Nucro-Technics Holdings, Inc. Nucro-Technics is a pharmaceutical contract research organization that conducts analytical chemistry, microbiology, toxicology, bioanalytical, and stability sample storage and testing services. In addition, it provides consulting services, especially in [...]
As with every year in March, five thousand attendees throughout the pharmaceutical and biotech industry converge on a city in the United States for the Society of Toxicology ToxExpo Meeting / Conference. These attendees are there to attend more than 2,000 presentations and meet with more than 250 exhibitors throughout Canada, the United States, [...]
In order to meet the safety standards enforced by regulatory authorities, food commodities and botanicals are required to undergo pesticide residue testing. The tests described in the U.S. Pharmacopoeia <561> “Articles of Botanical Origin” and the European SANTE/11813/2017 guidance documents allow for the quantitative and qualitative analysis of these pesticide residues. These analyses are [...]
The COVID-19 pandemic is serious and affects us all. Nucro-Technics is a business that has been deemed an essential service. Put simply, as part of our routine activities, the testing that we do allows for drugs to be released into the market. These are drugs that are being used to help treat people with the [...]
Nucro-Technics is very pleased to announce that it has been approved by the Eurostars program as part of a consortium led by Addex Therapeutics. The project, named DiSARM FEAR, is for the development of a novel allosteric modulator to treat post-traumatic stress disorder (PTSD). This venture involves an international group of companies that span [...]
As with every year in June, twenty thousand attendees throughout the pharmaceutical and biotech industry converge on a city in the United States for the BIO Conference. These attendees cover more than 1,000 biotech companies, academic institutions, regional hubs, and related organizations throughout Canada, the United States, and across the world. Nucro-Technics has been [...]
There is one month until cannabis is legalized in Canada. Judging by the activity that took place at the second annual Grow Up Conference and Expo from September 7-8, 2018, one can be excused from thinking that this has already happened. Hundreds of vendors were set up in the expo hall. Thousands of attendees [...]
